Metabolic syndrome-related kidney injury: a review and update

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study

Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,769 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

A core gut microbiome in obese and lean twins

Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · see citing works

The Global Epidemic of the Metabolic Syndrome

Saklayen, M. G. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0812-z · Cited by 3,990 · see citing works

GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art

Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101102 · Cited by 1,647 · see citing works

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020786 · Cited by 1,441 · see citing works

Prevalence of the Metabolic Syndrome Defined by the International Diabetes Federation Among Adults in the U.S.

Ford, E. S. (2005) · Diabetes Care · doi:10.2337/diacare.28.11.2745 · Cited by 1,191 · see citing works

Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012

Moore, J. X., Chaudhary, N. S., & Akinyemiju, T. (2017) · Preventing Chronic Disease · doi:10.5888/pcd14.160287 · Cited by 940 · see citing works

Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016

Hirode, G., & Wong, R. J. (2020) · JAMA · doi:10.1001/jama.2020.4501 · Cited by 936 · see citing works

Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis

D’Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman‐Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 726 · see citing works

Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid mice

Lee, R. H., Seo, M. J., Reger, R. L., Spees, J. L., Pulin, A. A., Olson, S. D., & Prockop, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608249103 · Cited by 711 · see citing works

Glomerular hyperfiltration: definitions, mechanisms and clinical implications

Helal, I., Fick-Brosnahan, G. M., Reed-Gitomer, B., & Schrier, R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.19 · Cited by 673 · see citing works

Metabolic syndrome and cardiovascular diseases: Going beyond traditional risk factors

Rossi, J. L. S., Barbalho, S. M., de Araújo, R. R., Bechara, M. D., Sloan, K. P., & Sloan, L. A. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3502 · Cited by 606 · see citing works

Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis

Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02180311 · Cited by 553 · see citing works

Obesity, hypertension, and chronic kidney disease

Hall, J., Juncos, L., Wang, Z., Hall, M., do Carmo, J., & da Silva, A. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39739 · Cited by 520 · see citing works

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

Remuzzi, G., Perico, N., Macia, M. L., & Ruggenenti, P. L. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09911.x · Cited by 505 · see citing works

Insulin Signaling to the Glomerular Podocyte Is Critical for Normal Kidney Function

Welsh, G. I., Hale, L. J., Eremina, V., Jeansson, M., Maezawa, Y., Lennon, R., Pons, D. A., Owen, R. J., Satchell, S. C., Miles, M. J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.015 · Cited by 466 · see citing works

Quercetin and metabolic syndrome: A review

Hosseini, A., Razavi, B. M., Banach, M., & Hosseinzadeh, H. (2021) · Phytotherapy Research · doi:10.1002/ptr.7144 · Cited by 390 · see citing works

Weight Loss Interventions in Chronic Kidney Disease

Navaneethan, S. D., Yehnert, H., Moustarah, F., Schreiber, M. J., Schauer, P. R., & Beddhu, S. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02250409 · Cited by 386 · see citing works

Role of Hyperinsulinemia and Insulin Resistance in Hypertension: Metabolic Syndrome Revisited

da Silva, A. A., do Carmo, J. M., Li, X., Wang, Z., Mouton, A. J., & Hall, J. E. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.02.066 · Cited by 381 · see citing works

Prevalence of metabolic syndrome in mainland china: a meta-analysis of published studies

Li, R., Li, W., Lun, Z., Zhang, H., Sun, Z., Kanu, J. S., Qiu, S., Cheng, Y., & Liu, Y. (2016) · BMC Public Health · doi:10.1186/s12889-016-2870-y · Cited by 369 · see citing works

Sterol regulatory element binding protein 1 couples mechanical cues and lipid metabolism

Bertolio, R., Napoletano, F., Mano, M., Maurer‐Stroh, S., Fantuz, M., Zannini, A., Bicciato, S., Sorrentino, G., & Sal, G. D. (2019) · Nature Communications · doi:10.1038/s41467-019-09152-7 · Cited by 296 · see citing works

Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension

Muñoz‐Durango, N., Fuentes, C., Castillo, A., González-Gómez, L. M., Vecchiola, A., Fardella, C., & Kalergis, A. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17070797 · Cited by 288 · see citing works

Leptin Function and Regulation

Zhang, Y., & Chua, S. C. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160041 · Cited by 270 · see citing works

Metabolic Syndrome and Risk of Acute Myocardial Infarction

Mente, A., Yusuf, S., Islam, S., McQueen, M., Tanomsup, S., Onen, C. L., Rangarajan, S., Gerstein, H. C., & Anand, S. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.12.053 · Cited by 261 · see citing works

[Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)].

(2022) · PubMed · doi:10.3760/cma.j.cn112138-20211027-00751 · Cited by 258 · see citing works

Role of adipose tissue renin–angiotensin system in metabolic and inflammatory diseases associated with obesity

Yvan‐Charvet, L., & Quignard‐Boulangé, A. (2010) · Kidney International · doi:10.1038/ki.2010.391 · Cited by 217 · see citing works

Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome

Bernini, L. J., Simão, A. N. C., Alfieri, D. F., Lozovoy, M. A. B., Mari, N. L., de Souza, C. H. B., Dichi, I., & Costa, G. N. (2015) · Nutrition · doi:10.1016/j.nut.2015.11.001 · Cited by 212 · see citing works

Immunologic and endocrine functions of adipose tissue: implications for kidney disease

Zhu, Q., & Scherer, P. E. (2018) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.157 · Cited by 200 · see citing works

Impact of different ectopic fat depots on cardiovascular and metabolic diseases

Ferrara, D., Montecucco, F., Dallegri, F., & Carbone, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28821 · Cited by 195 · see citing works

Bariatric surgery is associated with improvement in kidney outcomes

Chang, A. R., Chen, Y., Still, C. D., Wood, G. C., Kirchner, H. L., Lewis, M. W., Kramer, H., Hartle, J. E., Carey, D. J., Appel, L. J., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.02.039 · Cited by 185 · see citing works

Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study

Athyros, V. G., Mikhailidis, D. P., Liberopoulos, E. N., Kakafika, A. I., Karagiannis, A. I., Papageorgiou, A. A., Τζιόμαλος, Κ., Ganotakis, E. S., & Elisaf, M. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl538 · Cited by 181 · see citing works

The Renin Angiotensin Aldosterone System in Obesity and Hypertension

Cabandugama, P. K., Gardner, M. J., & Sowers, J. R. (2017) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.009 · Cited by 168 · see citing works

Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction

Gu, P., & Xu, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9230-8 · Cited by 160 · see citing works

GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanisms

Rizzo, M., Nikolic, D., Patti, A. M., Mannina, C., Montalto, G., McAdams, B. S., Rizvi, A. A., & Cosentino, F. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.05.012 · Cited by 152 · see citing works

Metabolic Syndrome and the Development of CKD in American Indians: The Strong Heart Study

Lucove, J. C., Vupputuri, S. X., HEISS, G. M., North, K. E., & Russell, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.09.014 · Cited by 148 · see citing works

Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury

Burger, D. E., Thibodeau, J.-F., Holterman, C. E., Burns, K. D., Touyz, R. M., & Kennedy, C. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070763 · Cited by 142 · see citing works

Visceral adiposity syndrome

Lopes, H. F., Corrêa‐Giannella, M. L., Consolim‐Colombo, F. M., & Egan, B. M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0156-2 · Cited by 139 · see citing works

Characteristics of healthy vascular ageing in pooled population-based cohort studies

Nilsson, P. M., Laurent, S., Cunha, P., Olsen, M. H., Rietzschel, E. R., Franco, O. H., Ryliškytė, L., Strazhesko, I. D., Vlachopoulos, C. V., Chen, C., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001824 · Cited by 132 · see citing works

Obesity, estrogens and adipose tissue dysfunction - implications for pulmonary arterial hypertension

Mair, K. M., Gaw, R., & MacLean, M. R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020952023 · Cited by 129 · see citing works

Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies

Li, X., Li, X., Lin, H., Fu, X., Lin, W., Li, M., Zeng, X., & Gao, Q. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.01.018 · Cited by 125 · see citing works

Exercise augments weight loss induced improvement in renal function in obese metabolic syndrome individuals

Straznicky, N. E., Grima, M. T., Lambert, É., Eikelis, N., Dawood, T., Lambert, G. W., Nestel, P. J., Masuo, K., Sari, C. I., Chopra, R., et al. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e3283418875 · Cited by 123 · see citing works

Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation

Zibadi, S., Rohdewald, P. J., Park, D., & WATSON, R. R. (2008) · Nutrition Research · doi:10.1016/j.nutres.2008.03.003 · Cited by 119 · see citing works

The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort.

Kitiyakara, C., Yamwong, S., Cheepudomwit, S., Domrongkitchaiporn, S., Unkurapinun, N., Pakpeankitvatana, V., & Sritara, P. (2007) · Kidney International · doi:10.1038/sj.ki.5002128 · Cited by 113 · see citing works

Prevalence and risk factors of metabolic syndrome among Asian Indians: A community survey

Ravikiran, M., Bhansali, A. K., Ravikumar, P., Bhansali, S., Dutta, P. R., Thakur, J. S., Sachdeva, N. K., Bhadada, S. K., & Walia, R. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.03.010 · Cited by 110 · see citing works

The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing Metabolic Syndrome among Malays in Kuala Lumpur

Moy, F. M., & Bulgiba, A. M. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-678 · Cited by 109 · see citing works

Dietary Strategies for Management of Metabolic Syndrome: Role of Gut Microbiota Metabolites

Croci, S., D'Apolito, L. I., Gasperi, V., Catani, M. V., & Savini, I. (2021) · Nutrients · doi:10.3390/nu13051389 · Cited by 108 · see citing works

Kidney Pathological Changes in Metabolic Syndrome: A Cross-sectional Study

Alexander, M. P., Patel, T. V., Farag, Y. M. K., Flórez, A., Rennke, H. G., & Singh, A. K. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.01.255 · Cited by 107 · see citing works

11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?

Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 107 · see citing works

Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease

Och, A., Och, M., Nowak, R., Podgórska, D., & Podgórski, R. (2022) · Molecules · doi:10.3390/molecules27041351 · Cited by 104 · see citing works

Hypertension in Metabolic Syndrome: Novel Insights

Katsimardou, A., Imprialos, K. P., Stavropoulos, K., Sachinidis, A. G., Doumas, M. N., & Athyros, V. G. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415161813 · Cited by 103 · see citing works

Prevalence of Metabolic Syndrome in Urban Pakistan (Karachi): Comparison of Newly Proposed International Diabetes Federation and Modified Adult Treatment Panel III Criteria

Hydrie, M. Z. I., Shera, A. S., Fawwad, A., Basit, A., & Hussain, A. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0055 · Cited by 90 · see citing works

Metabolic Syndrome, ESRD, and Death in CKD

Navaneethan, S. D., Schold, J. D., Kirwan, J. P., Arrigain, S., Jolly, S. E., Poggio, E. D., Beddhu, S., & Nally, J. V. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.09870912 · Cited by 87 · see citing works

Kidney outcomes three years after bariatric surgery in severely obese adolescents

Nehus, E. J., Khoury, J. C., Inge, T. H., Xiao, N., Jenkins, T. M., Moxey‐Mims, M., & Mitsnefes, M. M. (2016) · Kidney International · doi:10.1016/j.kint.2016.09.031 · Cited by 86 · see citing works

Childhood Obesity and the Metabolic Syndrome

Nehus, E. J., & Mitsnefes, M. M. (2018) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2018.08.004 · Cited by 80 · see citing works

Oral supplementation with glycine reduces oxidative stress in patients with metabolic syndrome, improving their systolic blood pressure

Díaz-Flores, M., Cruz, M., Durán-Reyes, G., Munguía-Miranda, C., Loza‐Rodriguez, H., Pulido-Casas, E., Torres‐Ramírez, N., Gaja-Rodriguez, O., Kumate, J., Baiza-Gutman, L. A., et al. (2013) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0341 · Cited by 77 · see citing works

Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men

Fife, E., Kostka, J., Kroc, Ł., Guligowska, A., Pigłowska, M., Sołtysik, B. K., Kaufman‐Szymczyk, A., Fabianowska‐Majewska, K., & Kostka, T. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0888-y · Cited by 77 · see citing works

Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort

Pammer, L. M., Lamina, C., Schultheiß, U. T., Kotsis, F., Kollerits, B., Stockmann, H., Lipovsek, J., Meiselbach, H., Busch, M., Eckardt, K., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13355 · Cited by 77 · see citing works

Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia

Gilani, S. I., Anderson, U. D., Jayachandran, M., Weissgerber, T. L., Zand, L., White, W., Milic, N. M., Suarez, M. L. G., Vallapureddy, R. R., Nääv, Å., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111202 · Cited by 76 · see citing works

Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass

Aminian, A., Daigle, C. R., Romero‐Talamás, H., Kashyap, S. R., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.01.025 · Cited by 74 · see citing works

Underlying Mechanisms of Renal Lipotoxicity in Obesity

Escasany, E., Izquierdo‐Lahuerta, A., & Medina‐Gómez, G. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000494694 · Cited by 73 · see citing works

Kidney function in metabolic syndrome may be improved with Pycnogenol®.

Stuard, S., Belcaro, G., Cesarone, M. R., Ricci, A., Dugall, M., Cornelli, U., Gizzi, G., Pellegrini, L., & Rohdewald, P. J. (2010) · PubMed · Cited by 72 · see citing works

Association of Visceral Fat Area with Chronic Kidney Disease and Metabolic Syndrome Risk in the General Population: Analysis Using Multi-Frequency Bioimpedance

Kang, S. H., Cho, K. H., Park, J. W., Yoon, K. W., & Do, J. Y. (2015) · Kidney and Blood Pressure Research · doi:10.1159/000368498 · Cited by 72 · see citing works

Physiological role of adiponectin in different tissues: a review

Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 71 · see citing works

Metabolic Syndrome Increases the Risk of Kidney Stone Disease: A Cross-Sectional and Longitudinal Cohort Study

Chang, C., Ke, H., Lee, J., Lee, Y., Jhan, J., Wang, H.-S., Shen, J.-T., Tsao, Y.-H., Huang, S., & Geng, J. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111154 · Cited by 70 · see citing works

Telmisartan Ameliorates Nephropathy in Metabolic Syndrome by Reducing Leptin Release From Perirenal Adipose Tissue

Li, H., Li, M., Liu, P., Wang, Y., Zhang, H., Li, H., Yang, S.-F., Song, Y., Yin, Y., Gao, L., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07008 · Cited by 66 · see citing works

Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients

Kwon, S. H., Woollard, J. R., Saad, A., Garovic, V. D., Zand, L., Jordan, K. L., Textor, S. C., & Lerman, L. O. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw077 · Cited by 65 · see citing works

Coordinated Contribution of NADPH Oxidase- and Mitochondria-Derived Reactive Oxygen Species in Metabolic Syndrome and Its Implication in Renal Dysfunction

Lee, H., & José, P. A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.670076 · Cited by 63 · see citing works

Mechanisms linking the renin-angiotensin system, obesity, and breast cancer

Rasha, F. A., Ramalingam, L., Gollahon, L., Rahman, R. L., Rahman, S. M., Menikdiwela, K. R., & Moustaïd‐Moussa, N. (2019) · Endocrine Related Cancer · doi:10.1530/erc-19-0314 · Cited by 62 · see citing works

Impact of treating the metabolic syndrome on chronic kidney disease

Agrawal, V., Shah, A., Rice, C., Franklin, B. A., & McCullough, P. A. (2009) · Nature Reviews Nephrology · doi:10.1038/nrneph.2009.114 · Cited by 62 · see citing works

Vildagliptin Stimulates Endothelial Cell Network Formation and Ischemia-induced Revascularization via an Endothelial Nitric-oxide Synthase-dependent Mechanism

Ishii, M., Shibata, R., Kondo, K., Kambara, T., Shimizu, Y., Tanigawa, T., Bando, Y., Nishimura, M., Ouchi, N., & Murohara, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557835 · Cited by 61 · see citing works

Overview of the Physiology and Pathophysiology of Leptin With Special Emphasis on its Role in the Kidney

Nasrallah, M., & Ziyadeh, F. N. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.005 · Cited by 60 · see citing works

From Obesity to Chronic Kidney Disease: How Can Adipose Tissue Affect Renal Function?

Martín-Taboada, M., Vila‐Bedmar, R., & Medina‐Gómez, G. (2021) · The Nephron journals/Nephron journals · doi:10.1159/000515418 · Cited by 60 · see citing works

Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention

Yang, S., Cao, C., Deng, T., & Zhou, Z. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000507784 · Cited by 60 · see citing works

The anti-inflammatory pharmacology of Pycnogenol® in humans involves COX-2 and 5-LOX mRNA expression in leukocytes

Canali, R., Comitato, R., Schönlau, F., & Virgili, F. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.06.001 · Cited by 60 · see citing works

Abdominal obesity and metabolic syndrome in South Asians: prevention and management

Jayawardena, R., Sooriyaarachchi, P., & Misra, A. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1982381 · Cited by 58 · see citing works

Transforming Growth Factor-β1 as a Common Target Molecule for Development of Cardiovascular Diseases, Renal Insufficiency and Metabolic Syndrome

Aihara, K., Ikeda, Y., Yagi, S., Akaike, M., & Matsumoto, T. (2010) · Cardiology Research and Practice · doi:10.4061/2011/175381 · Cited by 58 · see citing works

New Pandemic: Obesity and Associated Nephropathy

Sharma, I., Liao, Y., Zheng, X., & Kanwar, Y. S. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.673556 · Cited by 57 · see citing works

Metabolic syndrome and its components are associated with increased chronic kidney disease risk: Evidence from a meta-analysis on 11 109 003 participants from 66 studies

Alizadeh, S., Ahmadi, M., Nejad, B. G., Djazayeri, A., & Shab‐Bidar, S. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13201 · Cited by 56 · see citing works

Effects of glycine on metabolic syndrome components: a review

Imenshahidi, M., & Hossenzadeh, H. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01720-3 · Cited by 54 · see citing works

Association of Metabolic Syndrome With Kidney Function and Histology in Living Kidney Donors

Ohashi, Y., Thomas, G., Nurko, S., Stephany, B. R., Fatica, R. A., Chiesa, A., Rule, A. D., Srinivas, T. R., Schold, J. D., Navaneethan, S. D., et al. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12369 · Cited by 52 · see citing works

Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome

Cao, C., & Su, M. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7295 · Cited by 52 · see citing works

Metabolic syndrome severity score and the progression of CKD

Wu, M., Shu, Y., Wang, L., Song, L., Chen, S., Liu, Y., Bi, J., Li, D., Yang, Y., Hu, Y., et al. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13646 · Cited by 50 · see citing works

Metabolic Syndrome Severity and Risk of CKD and Worsened GFR: The Jackson Heart Study

DeBoer, M. D., Filipp, S. L., Musani, S. K., Sims, M., Okusa, M. D., & Gurka, M. J. (2018) · Kidney & Blood Pressure Research · doi:10.1159/000488829 · Cited by 50 · see citing works

Impact of adipose tissue in chronic kidney disease development (Review)

Miricescu, D., Balan, D., Tulin, A., Știru, O., Vacaroiu, I., Mihai, D., Popa, C., Enyedi, M., Nedelea, A. S., Nica, A., et al. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9969 · Cited by 49 · see citing works

The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study

Kittiskulnam, P., Thokanit, N. S., Katavetin, P., Susanthitaphong, P., Srisawat, N., Praditpornsilpa, K., Tungsanga, K., & Eiam‐Ong, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196332 · Cited by 49 · see citing works

Hyperglycemia induces vascular smooth muscle cell dedifferentiation by suppressing insulin receptor substrate-1–mediated p53/KLF4 complex stabilization

Xi, G., Shen, X., Wai, C., White, M. F., & Clemmons, D. R. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005398 · Cited by 49 · see citing works

Fatty Kidney Disease: A New Renal And Endocrine Clinical Entity? Describing the Role of the Kidney in Obesity, Metabolic Syndrome, and Type 2 Diabetes

Mende, C. W., & EINHORN, D. F. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0568 · Cited by 47 · see citing works

The role of metabolic syndrome in sudden cardiac death risk: Recent evidence and future directions

Tirandi, A., Carbone, F., Montecucco, F., & Liberale, L. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13693 · Cited by 45 · see citing works

Berberine Relieves Metabolic Syndrome in Mice by Inhibiting Liver Inflammation Caused by a High-Fat Diet and Potential Association With Gut Microbiota

Li, J., Li, J., Ni, J., Zhang, C., Jia, J., Wu, G., Sun, H., & Wang, S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.752512 · Cited by 44 · see citing works

Gdf11 gene transfer prevents high fat diet-induced obesity and improves metabolic homeostasis in obese and STZ-induced diabetic mice

Lu, B., Zhong, J., Pan, J., Yuan, X., Ren, M., Jiang, L., Yang, Y., Zhang, G., Liu, D., & Zhang, C. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-02166-1 · Cited by 43 · see citing works

Atherosclerotic-nephropathy: an updated narrative review

Simeoni, M., Borrelli, S., Garofalo, C., Fuíano, G., Esposito, C., Comi, A., & Provenzano, M. (2020) · Journal of Nephrology · doi:10.1007/s40620-020-00733-0 · Cited by 43 · see citing works

Cardiovascular and Renal Effects of Weight Reduction in Obesity and the Metabolic Syndrome

Cohen, J. B., & Cohen, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-015-0544-2 · Cited by 42 · see citing works

World Health Organization-Defined Metabolic Syndrome Is a Better Predictor of Coronary Calcium Than the Adult Treatment Panel III Criteria in American Men Aged 40–49 Years

Takamiya, T., Zaky, W. R., Edmundowics, D., Kadowaki, T., Ueshima, H., Kuller, L. H., & Sekikawa, A. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2977 · Cited by 42 · see citing works

Amelioration of diet-induced metabolic syndrome and fatty liver with sitagliptin via regulation of adipose tissue inflammation and hepatic Adiponectin/AMPK levels in mice

Prakash, S., Rai, U., Kosuru, R., Tiwari, V. K., & Singh, S. (2019) · Biochimie · doi:10.1016/j.biochi.2019.11.005 · Cited by 41 · see citing works

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis

Beneit, N., Fernandez‐Garcia, C. E., Martı́n-Ventura, J. L., Perdomo, L., Escribano, Ó., Michel, J., García-Gómez, G., Fernández, S., Díaz-Castroverde, S., Egido, J., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0477-3 · Cited by 40 · see citing works

Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome

Schnackenberg, C. G., Costell, M. H., Krosky, D. J., Cui, J., Wu, C. W., Hong, V. S., Harpel, M. R., Willette, R. N., & Yue, T.-L. (2013) · BioMed Research International · doi:10.1155/2013/427640 · Cited by 39 · see citing works

Renoprotective role of bariatric surgery in patients with established chronic kidney disease

Morales, E., Porrini, E., Martín-Taboada, M., Lima, S. L., Vila‐Bedmar, R., de Pablos, I. G., Gómez, P., Rodríguez, E., Torres, L., Lanzón, B., et al. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa266 · Cited by 39 · see citing works

Leptin and chronic kidney diseases

Mao, S., Li, F., Liu, F., Jiang, S., Wu, L., & Zhang, J. (2018) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2018.1431278 · Cited by 38 · see citing works

Early podocyte injury and elevated levels of urinary podocyte-derived extracellular vesicles in swine with metabolic syndrome: role of podocyte mitochondria

Zhang, L.-H., Zhu, X.-Y., Eirin, A., Nargesi, A. A., Woollard, J. R., Santelli, A., Sun, I. O., Textor, S. C., & Lerman, L. O. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00399.2018 · Cited by 37 · see citing works

Association between metabolic syndrome and incident chronic kidney disease among Chinese: A nation‐wide cohort study and updated meta‐analysis

Wu, N., Yao, Q., Chen, S., Yu, C., Xu, Y., Zhao, J., Yang, X., Li, N., & Pan, X. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3437 · Cited by 37 · see citing works

The kielin/chordin-like protein (KCP) attenuates high-fat diet-induced obesity and metabolic syndrome in mice

Soofi, A. A., Wolf, K. I., Emont, M. P., Qi, N., Martinez-Santibañez, G., Grimley, E. C., Ostwani, W., & Dressler, G. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.771428 · Cited by 36 · see citing works

Metabolic syndrome and chronic kidney disease in general Chinese adults: results from the 2007-08 China National Diabetes and Metabolic Disorders Study.

Jie, M., Xu, S., Yang, C., Gao, B., Wan, Y., Xing, Y., Zhang, L., Yang, W.-Y., & Ji, Q. (2014) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2014.01.004 · Cited by 36 · see citing works

FBXW7 mediates high glucose‑induced SREBP‑1 expression in renal tubular cells of diabetic nephropathy under PI3K/Akt pathway regulation

Li, L., Yang, J., Li, F., Zhu, L., & Hao, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11872 · Cited by 34 · see citing works

Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction

Lau, E. S., Paniagua, S. M., Zarbafian, S., Hoffman, U., Long, M. T., Hwang, S., Courchesne, P. L., Yao, C., Ma, J., Larson, M. G., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020215 · Cited by 34 · see citing works

Metabolic Syndrome, and Not Obesity, Is Associated with Chronic Kidney Disease

Ciardullo, S., Ballabeni, C., Trevisan, R., & Perseghin, G. (2021) · American Journal of Nephrology · doi:10.1159/000518111 · Cited by 34 · see citing works

Renal damage in the metabolic syndrome (MetSx): Disorders implicated

Joyce, T., Chirino, Y. I., Martínez‐Tagüeña, N., & Pedraza‐Chaverrí, J. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.032 · Cited by 30 · see citing works

Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes

Stutz, B., Ahola, A. J., Harjutsalo, V., Forsblom, C. M., & Groop, P. (2018) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2018.01.011 · Cited by 30 · see citing works

Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition

Herat, L. Y., Matthews, J. R., Azzam, O., Schlaich, M. P., & Matthews, V. B. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01170-z · Cited by 30 · see citing works

Weight loss intervention reduces the risk of kidney stone formation in a rat model of metabolic syndrome

Sasaki, Y., Kohjimoto, Y., Iba, A., Matsumura, N., & Hara, I. (2015) · International Journal of Urology · doi:10.1111/iju.12691 · Cited by 29 · see citing works

Metabolic syndrome is a predictor of decreased renal function among community-dwelling middle-aged and elderly Japanese

Kawamoto, R., Akase, T., Ninomiya, D., Kumagi, T., & Kikuchi, A. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02320-0 · Cited by 29 · see citing works

Metabolic syndrome and Growth Differentiation Factor 15 in older adults

Carballo‐Casla, A., García‐Esquinas, E., Soto, A. B., Struijk, E. A., López‐García, E., Rodríguez‐Artalejo, F., & Ortolá, R. (2021) · GeroScience · doi:10.1007/s11357-021-00370-w · Cited by 29 · see citing works

Recommendations for revision of Chinese diagnostic criteria for metabolic syndrome: A nationwide study

Xing, Y., Xu, S., Jia, A., Cai, J., Zhao, M., Guo, J., Ji, Q., & Ming, J. (2017) · Journal of Diabetes · doi:10.1111/1753-0407.12578 · Cited by 28 · see citing works

Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes

Añón-Hidalgo, J., Catalán, V., Rodrı́guez, A., Ramírez, B., Silva, C., Galofré, J. C., Salvador, J., Frühbeck, G., & Gómez‐Ambrosi, J. (2019) · Aging · doi:10.18632/aging.101865 · Cited by 28 · see citing works

Metabolic Syndrome Increases Risk of Venous Thromboembolism Recurrence after Acute Pulmonary Embolism

Stewart, L. K., & Kline, J. A. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201907-518oc · Cited by 28 · see citing works

Osthol Ameliorates Kidney Damage and Metabolic Syndrome Induced by a High-Fat/High-Sugar Diet

García‐Arroyo, F. E., Gonzaga, G., Tapia, E., Muñoz-Jiménez, I., Manterola-Romero, L., Osorio‐Alonso, H., Arellano-Buendía, A. S., Pedraza‐Chaverrí, J., Roncal-Jiménez, C. A., Lanaspa, M. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052431 · Cited by 28 · see citing works

Down-regulation of Insulin Receptor Substrate 1 during Hyperglycemia Induces Vascular Smooth Muscle Cell Dedifferentiation

Xi, G., Wai, C., White, M. F., & Clemmons, D. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.758987 · Cited by 26 · see citing works

Human umbilical cord Wharton jelly cells promote extra-pancreatic insulin formation and repair of renal damage in STZ-induced diabetic mice

Maldonado, M., Huang, T.-H., Yang, L.-J., Xu, L., & Ma, L. (2017) · Cell Communication and Signaling · doi:10.1186/s12964-017-0199-5 · Cited by 26 · see citing works

Both insulin resistance and metabolic syndrome accelerate the progression of chronic kidney disease among Chinese adults: results from a 3-year follow-up study

Ma, A., Liu, F., Wang, C., Liang, K., Yan, F., Hou, X., Liu, J., & Chen, L. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1934-6 · Cited by 26 · see citing works

Advances in the non-invasive assessment of vascular dysfunction in metabolic syndrome and diabetes: Focus on endothelium, carotid mechanics and renal vessels

Bruno, R. M., Reesink, K. D., & Ghiadoni, L. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.09.004 · Cited by 26 · see citing works

Consequences of morbid obesity on the kidney. Where are we going?

Navarro-Díaz, M. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw094 · Cited by 24 · see citing works

Simple obesity and renal function.

Sikorska, D., Grzymisławska, M., Roszak, M., Gulbicka, P., Korybalska, K., & Witowski, J. (2017) · PubMed · Cited by 24 · see citing works

The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach

Marková, I., Miklánková, D., Hüttl, M., Kačer, P., Skibová, J., Kucera, J., Sedláček, R., Kačerová, T., Kazdová, L., & Malínská, H. (2019) · Journal of Diabetes Research · doi:10.1155/2019/8712979 · Cited by 24 · see citing works

Incidence and correlation of metabolic syndrome and kidney stones in a healthy screening population

Qiu, F., Xu, Y., Ji, X., Pu, J., Zhou, J., & Huang, Y. (2021) · Translational Andrology and Urology · doi:10.21037/tau-21-689 · Cited by 24 · see citing works

Early Microvascular Dysfunction: Is the Vasa Vasorum a “Missing Link” in Insulin Resistance and Atherosclerosis

Owusu, J., & Barrett, E. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147574 · Cited by 23 · see citing works

Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults

Min, S. H., Kim, S., Jeong, I., Cho, H., Jeong, J., Lee, J., Kang, H., Kim, H.-S., Park, K. S., & Lim, S. K. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0200 · Cited by 22 · see citing works

Attenuation of cold stress-induced exacerbation of cardiac and adipose tissue pathology and metabolic disorders in a rat model of metabolic syndrome by the glucocorticoid receptor antagonist RU486

Nagasawa, K., Matsuura, N., Takeshita, Y., Ito, S., Sano, Y., Yamada, Y., Uchinaka, A., Murohara, T., & Nagata, K. (2016) · Nutrition and Diabetes · doi:10.1038/nutd.2016.14 · Cited by 21 · see citing works

A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models

Oh, H., Jeong, K., Han, H. Y., Son, H. J., Kim, S. S., Lee, H. J., Kim, S., Sa, J. H., Jun, H., Ryu, J. H., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.042 · Cited by 19 · see citing works

Effects of antihypertensive medication and high‐intensity interval training in hypertensive metabolic syndrome individuals

Ramirez-Jimenez, M., Morales-Palomo, F., Moreno-Cabañas, A., Alvarez-Jimenez, L., Ortega, J., & Mora-Rodríguez, R. (2021) · Scandinavian Journal of Medicine & Science in Sports · doi:10.1111/sms.13949 · Cited by 19 · see citing works

Dapagliflozin, metformin, monotherapy or both in patients with metabolic syndrome

Cheng, L., Fu, Q.-Y., Zhou, L., Fan, Y., Liu, F.-F., Fan, Y.-Y., Zhang, X., Lin, W.-Z., & Wu, X. (2021) · Scientific Reports · doi:10.1038/s41598-021-03773-z · Cited by 19 · see citing works

Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome

Fu, C.-P., Sheu, W., Lee, I., Lee, W.-J., Wang, J.-S., Liang, K.-W., Lee, W.-L., & Lin, S.-Y. (2015) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm-2014-0468 · Cited by 18 · see citing works

Effect of atorvastatin on lipogenic, inflammatory and thrombogenic markers in women with the metabolic syndrome

Velarde, G., Choudhary, N., Bravo‐Jaimes, K., Smotherman, C. R., Sherazi, S., & Kraemer, D. F. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.10.002 · Cited by 18 · see citing works

Modulation of Renal Function in a Metabolic Syndrome Rat Model by Antioxidants in Hibiscus sabdariffa L.

Rodríguez-Fierros, F. L., Guarner‐Lans, V., Soto, M. E., Manzano-Pech, L., Díaz‐Díaz, E., Soria‐Castro, E., Rubio-Ruiz, M. E., Jiménez-Trejo, F. J., & Pérez-Torres, I. (2021) · Molecules · doi:10.3390/molecules26072074 · Cited by 18 · see citing works

Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation

Çiçek, F. A., Zeynep, T.-K., Özçınar, E., Bozkuş, Y., Can, A. K., & Belma, T. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3392-2 · Cited by 17 · see citing works

The Racial Disparities in the Epidemic of Metabolic Syndrome With Increased Age: A Study From 28,049 Chinese and American Adults

Zhang, R., Sun, J., Wang, C., Wang, X., Zhao, P. Z., Yuan, Y., Hu, A. C., & Zhou, Q. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.797183 · Cited by 17 · see citing works

Dapagliflozin and xanthine oxidase inhibitors improve insulin resistance and modulate renal glucose and urate transport in metabolic syndrome

Ng, H., Leung, F., Kuo, W., Lee, W., & Lee, C. (2021) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13574 · Cited by 16 · see citing works

Obesity and metabolic syndrome induce hyperfiltration, glomerulomegaly, and albuminuria in obese ovariectomized female mice and obese male mice

Rodríguez‐Rodríguez, A. E., Donate‐Correa, J., Lima, S. L., Martin, L. D., Rodríguez, C., Pérez, J. A., Acosta, N. G., Fumero, C., Navarro-Díaz, M., López, D., et al. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001842 · Cited by 16 · see citing works

The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.

Malur, P., Menezes, A. R., DiNicolantonio, J. J., O’Keefe, J. H., & Lavie, C. J. (2017) · Europe PMC (PubMed Central) · Cited by 16 · see citing works

Association between Dietary Patterns and Kidney Function Parameters in Adults with Metabolic Syndrome: A Cross-Sectional Study

Syauqy, A., Hsu, C., Lee, H.-A., Rau, H.-H., & Chao, J. C.-J. (2020) · Nutrients · doi:10.3390/nu13010040 · Cited by 15 · see citing works

The associations of eating behavior and dietary intake with metabolic syndrome in Japanese: Saku cohort baseline study

for the Saku Cohort Study Group, Morita, A., Aiba, N., Miyachi, M., & Watanabe, S. (2020) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-020-00250-w · Cited by 14 · see citing works

Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome

Eid, B. G., Neamatallah, T., Hanafy, A., El‐Bassossy, H. M., Binmahfouz, L. S., Aldawsari, H. M., Hasan, A., El-Aziz, G. S. A., Vemuri, K. V., & Makriyannis, A. (2021) · Molecules · doi:10.3390/molecules26040866 · Cited by 14 · see citing works

Benidipine Attenuates Glomerular Hypertension and Reduces Albuminuria in Patients with Metabolic Syndrome

Uzu, T., NISHIMURA, M., Fujii, T., SAKAGUCHI, M., Kanasaki, M., Isshiki, K., Araki, S., Sugiomoto, T., Kashiwagi, A., & Kimura, G. (2007) · Hypertension Research · doi:10.1291/hypres.30.161 · Cited by 13 · see citing works

Leptin, adiponectin, lipodystrophic and severe insulin resistance syndromes

Vatier, C., Jéru, I., Fellahi, S., Capeau, J., Bastard, J., & Vigouroux, C. (2020) · Annales de biologie clinique · doi:10.1684/abc.2020.1551 · Cited by 11 · see citing works

Association between management of metabolic syndrome and progression of early-stage chronic kidney disease: an observational cohort study

Lin, J., Wu, H., Huang, W., Lu, C.-L., Cheng, M.-H., Wang, H.-T., Yen, T., & Wang, W. (2014) · Renal Failure · doi:10.3109/0886022x.2014.964140 · Cited by 11 · see citing works

Acid Loading Unmasks Glucose Homeostatic Instability in Proximal-Tubule-Targeted Insulin/Insulin-Like-Growth-Factor-1 Receptor Dual Knockout Mice

Aljaylani, A., Fluitt, M. B., Piselli, A., Shepard, B. D., Tiwari, S., & ECELBARGER, C. A. (2020) · Cellular Physiology and Biochemistry · doi:10.33594/000000248 · Cited by 11 · see citing works

Stem cells as a potential therapy in managing various disorders of metabolic syndrome: a systematic review.

Shamsuddin, S. A., Chan, A. M. L., Ng, M. H., Yazid, M. D., Law, J. X., Idrus, R. B. H., Fauzi, M. B., Yunus, M. H. M., & Lokanathan, Y. (2021) · PubMed Central · Cited by 10 · see citing works

Metabolic syndrome in children

Tagi, V. M., Samvelyan, S., & Chiarelli, F. (2020) · Minerva Pediatrics · doi:10.23736/s0026-4946.20.05834-x · Cited by 9 · see citing works

Losartan and Eprosartan Induce a Similar Effect on the Acute Rise in Serum Uric Acid Concentration after an Oral Fructose Load in Patients with Metabolic Syndrome

Masajtis‐Zagajewska, A., Majer, J., & Nowicki, M. P. (2021) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1155/2021/2214978 · Cited by 9 · see citing works

Serum growth differentiation factor 11 is closely related to metabolic syndrome in a Chinese cohort

Xu, B., Huang, Y., Zhang, R., Tang, M., He, Z., Jin, L., Zong, Y., Hu, C., & Jia, W. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13337 · Cited by 8 · see citing works

Hyperhomocysteinemia Concurrent with Metabolic Syndrome Is Independently Associated with Chronic Kidney Disease among Community-Dwelling Adults in an Urban Korean Population

Moon, H., Ko, H., & Kim, A. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17186810 · Cited by 8 · see citing works

Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children

Correia‐Costa, L., Morato, M., Sousa, T., Cosme, D., Guimarães, J. T., Guerra, A., Schaefer, F. S., Afonso, A. C., Azevedo, A., & Albino‐Teixeira, A. (2015) · Pediatric Nephrology · doi:10.1007/s00467-015-3232-1 · Cited by 8 · see citing works

Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis

Stewart, L. K., Beam, D. M., Casciani, T., Cameron, S. J., & Kline, J. A. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.12.043 · Cited by 7 · see citing works

Association of metabolic syndrome traits with urinary biomarkers in Japanese adults

Kabasawa, K., Hosojima, M., Ito, Y., Matsushima, K., Tanaka, J., Hara, M., Nakamura, K., Narita, I., & Saito, A. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00779-5 · Cited by 7 · see citing works

Sterol regulatory element binding protein 1 trans-activates 25-hydroxy vitamin D3 24-hydroxylase gene expression in renal proximal tubular cells

Kagawa, T., Kozai, M., Masuda, M., Harada, N., Nakahashi, O., Tajiri, M., Yoshikawa, R., Nakao, M., Takei, Y., Iwano, M., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.058 · Cited by 5 · see citing works

Autopsy Patients With Obesity or Metabolic Syndrome as Basic Cause of Death: Are There Pathological Differences Between These Groups?

Gonçalves, L. B., Miot, H. A., Domingues, M. A. C., & Oliveira, C. C. (2018) · Clinical Medicine Insights Pathology · doi:10.1177/1179555718791575 · Cited by 4 · see citing works

Percutaneous transluminal renal angioplasty attenuates poststenotic kidney mitochondrial damage in pigs with renal artery stenosis and metabolic syndrome

Farahani, R. A., Afarideh, M., Zhu, X., Tang, H. J., Jordan, K. L., Saadiq, I. M., Ferguson, C. M., Lerman, A., Textor, S. C., Lerman, L. O., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30146 · Cited by 4 · see citing works

[An experience of the use of angiotensin II receptor blocker losartan in patients with metabolic syndrome and chronic kidney disease].

Beloborodova, A. V., Морозова, Т. Е., & Em, S. (2010) · PubMed · Cited by 2 · see citing works

[Treatment of dyslipidemia in patients with metabolic syndrome and chronic kidney disease].

Monhart, V. (2009) · PubMed · Cited by 2 · see citing works

Measuring the Effects of Berberine on Serum Prooxidant–Antioxidant Balance in Metabolic Syndrome

Jamialahmadi, T., Guest, P. C., Tasbandi, A., Al‐Rasadi, K., & Sahebkar, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1558-4_22 · Cited by 2 · see citing works

The Role of Inflammation in CKD

Kadatane, S., Satariano, M., Massey, M., Mongan, K., & Raina, R. (2023) · Cells · doi:10.3390/cells12121581 · Cited by 350 · see citing works

Association of metabolic syndrome and chronic kidney disease

Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024) · Obesity Reviews · doi:10.1111/obr.13649 · Cited by 155 · see citing works

Global, regional, and national burden of chronic kidney disease, 1990-2021: a systematic analysis for the global burden of disease study 2021

Xie, K., Cao, H., Ling, S., Zhong, J., Chen, H., Chen, P., & Huang, R. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1526482 · Cited by 107 · see citing works

Metabolic syndrome: epidemiology, mechanisms, and current therapeutic approaches

Hamooya, B. M., Siame, L., Muchaili, L., Masenga, S. K., & Kirabo, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1661603 · Cited by 88 · see citing works

The Metabolic Syndrome, a Human Disease

Alemany, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042251 · Cited by 85 · see citing works

Current Insights into the Effects of Dietary α-Linolenic Acid Focusing on Alterations of Polyunsaturated Fatty Acid Profiles in Metabolic Syndrome

Takić, M. M., Ranković, S., Girek, Z., Pavlović, S., Jovanović, P., Jovanović, V. B., & Šarac, I. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094909 · Cited by 70 · see citing works

A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches

Giangregorio, F., Mosconi, E., Debellis, M. G., Provini, S., Esposito, C., Garolfi, M., Oraka, S., KALOUDI, O., Mustafazade, G., Marín‐Baselga, R., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13195880 · Cited by 63 · see citing works

Elucidating ascorbate and aldarate metabolism pathway characteristics via integration of untargeted metabolomics and transcriptomics of the kidney of high-fat diet-fed obese mice

Liang, H., & Song, K. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300705 · Cited by 35 · see citing works

Exploring the nexus: The place of kidney diseases within the cardiovascular-kidney-metabolic syndrome spectrum

Kanbay, M., Güldan, M., Özbek, L., Çöpür, S., Covic, A. S., & Covic, A. C. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.07.014 · Cited by 37 · see citing works

Immune-mediated renal injury in diabetic kidney disease: from mechanisms to therapy

Ma, L., Liu, D., Yu, Y., Li, Z., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1587806 · Cited by 32 · see citing works

Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate “diseased” from “normal”

Kataoka, H., Nitta, K., & Hoshino, J. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1179834 · Cited by 27 · see citing works

Impact of Metabolic Syndrome Traits on Kidney Disease Risk in Individuals with MASLD : A UK Biobank Study

Bilson, J., Hydes, T., McDonnell, D., Buchanan, R. M., Scorletti, E., Mantovani, A., Targher, G., & Byrne, C. D. (2024) · Liver International · doi:10.1111/liv.16159 · Cited by 23 · see citing works

Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes

Esposito, P. B., Picciotto, D., Cappadona, F., Costigliolo, F., Russo, E., Macciò, L., & Viazzi, F. C. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i10.1450 · Cited by 23 · see citing works

Metabolic Syndrome, Kidney-Related Adiposity, and Kidney Microcirculation: Unraveling the Damage

Jang, K. W., Hur, J., Lee, D. W., & Kim, S. R. (2024) · Biomedicines · doi:10.3390/biomedicines12122706 · Cited by 24 · see citing works

A Genome-Wide Association Study of Metabolic Syndrome in the Taiwanese Population

Ho, C., Lee, J., Huang, S., Chen, S., & Geng, J. (2023) · Nutrients · doi:10.3390/nu16010077 · Cited by 20 · see citing works

A network toxicology and machine learning approach to investigate the mechanism of kidney injury from melamine and cyanuric acid co-exposure

Wang, Z., Zhou, Z., Zhao, Z., Zhang, J., Zhang, S., Li, L., Fan, Y., & Li, Q. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118029 · Cited by 19 · see citing works

Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure

López‐Baltanás, R., Rodríguez-Ortiz, M. E., Díaz‐Tocados, J. M., Martinez-Moreno, J. M., Membrives, C., Rodelo‐Haad, C., de Mier, M. V. P.-R., Rodríguez, M., Canalejo, A., Almadén, Y., et al. (2023) · Antioxidants · doi:10.3390/antiox12020283 · Cited by 19 · see citing works

Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism

Liu, Y., Wang, H., Geng, Y.-H., Han, L., Tu, S., & Wang, H. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1112088 · Cited by 19 · see citing works

Antioxidant and anti-inflammatory effects of allicin in the kidney of an experimental model of metabolic syndrome

Arellano-Buendía, A. S., Juárez-Rojas, J. G., García‐Arroyo, F. E., Aparicio‐Trejo, O. E., Sánchez‐Muñoz, F., Argüello-García, R., Sánchez‐Lozada, L. G., Bojalil, R., & Osorio‐Alonso, H. (2023) · PeerJ · doi:10.7717/peerj.16132 · Cited by 19 · see citing works

Dyslipidemia-induced renal fibrosis related to ferroptosis and endoplasmic reticulum stress

Jiang, Y., Zhu, X., Jordan, K. L., Li, Y., Conley, S. M., Tang, H., Lerman, A., Eirin, A., Ou, T., & Lerman, L. O. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100610 · Cited by 17 · see citing works

Obesity-Related Glomerulosclerosis—How Adiposity Damages the Kidneys

Zbrzeźniak, J., Winiarska, A., Perkowska‐Ptasińska, A., & Stompór, T. P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136247 · Cited by 16 · see citing works

Global burden of chronic kidney disease due to hypertension (1990–2021): a systematic analysis of epidemiological trends, risk factors, and projections to 2036 from the GBD 2021 study

He, Y., Tang, W., Chen, J., Tang, J., Zheng, Y., Wang, X., Xing, B., Li, X., Xu, Y., & Wang, X. (2025) · BMC Nephrology · doi:10.1186/s12882-025-04386-8 · Cited by 19 · see citing works

Astaxanthin improves lipotoxicity, lipid peroxidation and oxidative stress in kidney of sucrose-rich diet-fed rats

Joubert, M. B. V., Ingaramo, P. I., Collins, P., & D’Alessandro, M. E. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109779 · Cited by 15 · see citing works

Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor

Lin, L., Pan, X., Feng, Y., & Yang, J. (2024) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188241252309 · Cited by 13 · see citing works

Metabolic health's central role in chronic kidney disease progression: a 20-year study of obesity-metabolic phenotype transitions

Khalili, S., Safavi‐Naini, S. A. A., Zarand, P., Masoumi, S., Farsi, Y., Hosseinpanah, F., & Azizi, F. (2024) · Scientific Reports · doi:10.1038/s41598-024-56061-x · Cited by 13 · see citing works

From Metabolic Syndrome to Atrial Fibrillation: Linking Inflammatory and Fibrotic Biomarkers with Atrial Remodeling and Imaging-Based Evaluation—A Narrative Review

Merce, A.-G., Nisulescu, D. D., Hermenean, A. O., Burciu, O. M., Munteanu, I.-R., Merce, A.-P., Brie, D. M., & Mornoş, C. (2026) · Metabolites · doi:10.3390/metabo16010059 · Cited by 11 · see citing works

Exercise Testing for Metabolic Flexibility: Time for Protocol Standardization

Lovell, D. I., Stuelcken, M., & Eagles, A. N. (2025) · Sports Medicine - Open · doi:10.1186/s40798-025-00825-w · Cited by 12 · see citing works

Therapeutic potential of Lactobacillus casei and Chlorella vulgaris in high-fat diet-induced non-alcoholic fatty liver disease (NAFLD)-associated kidney damages: a stereological study

Keyghobadi, H., bozorgpoursavadjani, H., Koohpeyma, F., Mohammadipoor, N., Nemati, M., Dehghani, F., Jamhiri, I., Keighobadi, G., & Dastghaib, S. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09542-1 · Cited by 10 · see citing works

Prevalence of dyslipidemia and its associated risk factors in hypertensive population: A single-center cross-sectional study in southern China

Sun, J., Huang, B., Zhao, W., Li, Q., Yin, S., Zhang, Y., & Huang, R. (2025) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/14703203251353658 · Cited by 9 · see citing works

Gut microbiota-derived SCFAs and MetS-related nephropathy

Tian, X., Sun, L., Guo, S., Yuan, L., Zhang, T., Huang, C., He, T., Jiang, Q., & Zeng, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1561271 · Cited by 9 · see citing works

Higher oxidative balance score is linearly associated with reduced prevalence of chronic kidney disease in individuals with metabolic syndrome: evidence from NHANES 1999–2018

Zhu, L., Ruan, X., Wang, J., Yan, Y., Tang, C., & Xu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1442274 · Cited by 8 · see citing works

Balancing Stone Prevention and Kidney Function: A Therapeutic Dilemma

Stepanova, N. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14113678 · Cited by 11 · see citing works

Individualized Diets in Patients with Kidney Disease and Kidney Transplants: A Narrative Review

Hu, L., Borelli, G., Gessaroli, E., Ruotolo, C., Bin, S., Papalia, G., Patella, G., Liberti, M. E., Baraldi, O., Zaza, G., et al. (2025) · Life · doi:10.3390/life15060896 · Cited by 9 · see citing works

Metabolic disorder–associated kidney disease and diabetic kidney disease in developing countries

Bavanandan, S., Noronha, I. L., Tchokhonelidze, I., & Liew, A. (2025) · Kidney International · doi:10.1016/j.kint.2025.03.034 · Cited by 8 · see citing works

The Role of Comorbidities in COVID-19 Severity

König, S., Vaskyte, U., Boesing, M., Lüthi-Corridori, G., & Leuppi, J. D. (2025) · Viruses · doi:10.3390/v17070957 · Cited by 8 · see citing works

Association between oxidative balance score and diabetic kidney disease, low estimated glomerular filtration rate and albuminuria in type 2 diabetes mellitus patients: a cross-sectional study

Liu, C., Yang, J., Li, H., Deng, Y., He, P., Zhang, J., & Zhang, M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1412823 · Cited by 7 · see citing works

Effects of Metabolic Syndrome and Its Components on Chronic Kidney Disease and Renal Function: A Two-Sample Mendelian Randomization Study

Yang, H., Cui, Z., & Quan, Z. (2023) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0161 · Cited by 7 · see citing works

Metabolic syndrome–associated kidney disease in young adolescents and children

Raina, R., Hu, J., Chan, E. Y.-H., Hinton, J., & Mitsnefes, M. M. (2025) · Kidney International · doi:10.1016/j.kint.2025.04.036 · Cited by 6 · see citing works

Sex differences in the progression of cardiovascular–kidney–metabolic syndrome

Taya, S., Ejiri, K., Kaneko, H., Suzuki, Y., Miyoshi, T., Mizuno, A., Ko, T., Jimba, T., Azegami, T., Okada, A., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf162 · Cited by 6 · see citing works

Associations between metabolic profiles and incident CKD in the Chinese population aged 45–85 years

Zhu, B., Shi, Y., Song, N., Zhao, S., Shen, B., Wang, J., Zhang, W., Lu, Y., Fang, Y., Ding, X., et al. (2024) · International Urology and Nephrology · doi:10.1007/s11255-023-03916-3 · Cited by 6 · see citing works

ACUTE KIDNEY INJURY FOLLOWING ACUTE CHOLANGITIS: A RISK MULTIPLIER FOR ADVERSE OUTCOMES AND HEALTHCARE UTILIZATION

Tang, L., Wan, W., Zhang, J., Zhang, H., Wang, Y., & Li, X. (2024) · Shock · doi:10.1097/shk.0000000000002462 · Cited by 6 · see citing works

De Novo Metabolic Syndrome 1 Year after Liver Transplantation and Its Association with Mid- and Long-Term Morbidity and Mortality in Liver Recipients

Czarnecka, K., Czarnecka, P., Tronina, O., Bączkowska, T., & Durlik, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13061719 · Cited by 6 · see citing works

Metabolic dysfunction, rather than obesity, is a risk factor for chronic kidney disease in Chinese population

Yang, S., Ling, J., Zhang, S., Li, Y., & Yang, G. (2024) · The Aging Male · doi:10.1080/13685538.2024.2335158 · Cited by 6 · see citing works

Impact of Smoking, Body Weight, Diabetes, Hypertension and Kidney Dysfunction on Survival in Pancreatic Cancer Patients—A Single Center Analysis of 2323 Patients within the Last Decade

Neumann, C., Schneider, F., Hilfenhaus, G., Vecchione, L., Benzing, C., Ihlow, J., Fehrenbach, U., Malinka, T., Keilholz, U., Stintzing, S., et al. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113656 · Cited by 6 · see citing works

Multi‐target Drugs to Treat Metabolic Diseases

Lillich, F. F., Goorani, S., Proschak, E., & Imig, J. D. (2024) · doi:10.1002/9781394182862.ch13 · Cited by 6 · see citing works

Unraveling the Connection between PCOS and renal Complications: Current insights and Future Directions

Peng, H., Ren, J., Zhao, Y., Fang, X., Wang, X., Liu, C., & Wan, Z. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112235 · Cited by 5 · see citing works

Metabolic syndrome and kidney dysfunction: emerging molecular and cellular mechanisms at the metabolic–renal interface

Marshall, W. R., Green, D., Sinha, S., & Kalra, P. A. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1785937 · Cited by 5 · see citing works

Cost-effectiveness of behavioural counselling intervention compared with non-intervention for adult patients with metabolic syndrome to prevent cardiovascular diseases and type 2 diabetes in Japan: a microsimulation modelling study

Akune, Y., Anezaki, H., Nakao, Y. M., & Goto, R. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-072688 · Cited by 5 · see citing works

Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease?

Bai, J., Zhang, L., He, L., & Zhou, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1613640 · Cited by 6 · see citing works

Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management

Lian, K., Zhang, K., Kan, C., Hou, N., Han, F., Sun, X., Qiu, H., & Guo, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122801 · Cited by 4 · see citing works

Enhancing Metabolic Syndrome Detection through Blood Tests Using Advanced Machine Learning

Paplomatas, P., Rigas, D., Sergounioti, A., & Vrahatis, A. G. (2024) · Eng—Advances in Engineering · doi:10.3390/eng5030075 · Cited by 4 · see citing works

Mendelian Randomization Studies: Opening a New Window in the Study of Metabolic Diseases and Chronic Kidney Disease

Liang, N., Ma, X., Cao, Y., Liu, T., Fang, J., & Zhang, X. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303288685240808073238 · Cited by 4 · see citing works

From Metabolic Syndrome to Cardio-Kidney-Metabolic Syndrome in the SIMETAP Study: Prevalence Rates of Metabolic Syndrome and Its Independent Associations with Cardio-Renal-Metabolic Disorders Other than Its Defining Criteria

Ruiz‐García, A., Arranz-Martínez, E., Serrano-Cumplido, A., Cinza‐Sanjurjo, S., Escobar, C., García, J. P., & Pallarés‐Carratalá, V. (2025) · Biomedicines · doi:10.3390/biomedicines13030590 · Cited by 4 · see citing works

Changes in metabolic syndrome status and risk of chronic kidney disease over a decade of follow-up in the Iranian population

Kabootari, M., Tirtashi, R. H., Amouzegar, A., Masoumi, S., Azizi, F., & Amouzegar, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-03690-5 · Cited by 4 · see citing works

Differential Proneness to Obesity in Two Rat Strains with Diverse Immune Responses

Tucović, D., Aleksandrov, A. P., Popović, D., Malešević, A., Subota, V., Brdarić, E., Bajić, S. S., Živković, M., Kataranovski, M. V., Mirkov, I. I., et al. (2025) · Biology · doi:10.3390/biology14050557 · Cited by 3 · see citing works

Association of Visceral Adiposity with Nephropathy in Patients with Diabetes Mellitus: Data from Chinese and US Cohorts

Zhang, F., & Li, W. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s516687 · Cited by 3 · see citing works

Lipid metabolism disorders and albuminuria risk: insights from National Health and Nutrition Examination Survey 2001–2018 and Mendelian randomization analyses

Wang, Y., & Li, S. (2024) · Renal Failure · doi:10.1080/0886022x.2024.2420841 · Cited by 3 · see citing works

Nonlinear relationship between serum Klotho and chronic kidney disease in US adults with metabolic syndrome

Lin, X., & Yang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1409560 · Cited by 3 · see citing works

Non-enzymatic modification of aminophospholipids induces angiogenesis, inflammation, and insulin signaling dysregulation in human renal glomerular endothelial cells in vitro

Rodríguez-Mortera, R., Torres, P., Fernàndez‐Bernal, A., Berdún, R., Ramírez‐Núñez, O., Martin‐Garí, M., Serrano, J. C. E., He, C., Prat, J., Pamplona, R., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.030 · Cited by 3 · see citing works

Dynamic changes in metabolic syndrome components and chronic kidney disease risk: a population-based prospective cohort study

Huang, Y., Fu, R., Zhang, J., Zhou, J., Chen, S., Lin, Z., Xie, X., & Hu, Z. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-01958-5 · Cited by 3 · see citing works

Relation between erythropoietin resistance and metabolic syndrome in hemodialysis patients: A multicentric propensity score matched analysis

Kotb, E., mancy, I. M. E., Mohamed, I. G. R., Ayoub, H. S. A., Rashed, A.-S. M., EL-Nasser, W. S., Hamed, H. I., Aladl, H. A. A., Sabrh, M. A. M., Eliwa, A., et al. (2023) · Journal of Investigative Medicine · doi:10.1177/10815589231171405 · Cited by 3 · see citing works

Renal damage in Hepatorenal Syndrome: A still unsolved issue

Calleri, A., & Alessandria, C. (2023) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2023.102178 · Cited by 3 · see citing works

The association between the amount and timing of coffee consumption with chronic kidney disease in diabetic patients

Tang, Y., Zhou, Q., Zhao, N., Niu, F., Li, S., Zuo, Y., Huang, J., Wang, Z., Han, T., & Wei, W. (2024) · Food & Function · doi:10.1039/d4fo02777a · Cited by 3 · see citing works

Association Between Oxidative–Inflammation Biomarkers and Incident Chronic Kidney Disease in People with High Cardiovascular Risk: A Nested Case–Control Study

Quetglas‐Llabrés, M. M., Díaz‐López, A., Bouzas, C., Monserrat-Mesquida, M., Salas‐Salvadó, J., Ruiz‐Canela, M., Martínez, J. A., Santos‐Lozano, J. M., García, S., Estruch, R., et al. (2025) · Antioxidants · doi:10.3390/antiox14080975 · Cited by 2 · see citing works

Exploring the link between selective glomerular filtration and intima media thickness

Lundbergs, R., Annell, N. B., Kennbäck, C., Jujić, A., Holm, H., Christensson, A. G., & Laučytė-Cibulskienė, A. (2025) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2025.2585472 · Cited by 2 · see citing works

Machine Learning Prediction of Chronic Kidney Disease in Elderly MetS Patients Using NHANES 2011–2020 Data

Du, Y., & Wang, K. (2025) · Rejuvenation Research · doi:10.1177/15491684251399607 · Cited by 2 · see citing works

Gut Microbiota Dysbiosis and Metabolite Imbalance Mediate Diabetic Kidney Disease Inflammation: Mechanisms and Intervention Strategies Targeting Gut-Kidney Axis and NF-κB/NLRP3 Pathways

Liang, H., Liu, Z., Zhao, N., Lei, S., Zhu, S., & Ma, J. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s583563 · Cited by 2 · see citing works

Consensus Interdisciplinary Positions of the Metabolic Syndrome Supervisory Committee

Shlyakhto, E. V., Arutyunov, G. P., Babenko, A. Y., Boytsov, S. A., Вадимовна, В. С., Dedov, I. I., Drapkina, O. M., Олеговна, Е. С., Звартау, Н. Э., Ivashkin, V. T., et al. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-7130 · Cited by 3 · see citing works

Analysis of metabolic syndrome in bilateral upper urinary tract stones: A retrospective study of 3905 cases

Li, Z., Fu, C. Y., Sun, C., Suo, Y., Li, K., & Qi, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31180 · Cited by 2 · see citing works

Cardiometabolic traits mediating the effect of education on the risk of DKD and CKD: a Mendelian randomization study

Wang, Y., Chen, M., Wang, L., & Wu, Y. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1400577 · Cited by 2 · see citing works

Magnolol Inhibits High Fructose-Induced Podocyte Inflammation via Downregulation of TKFC/Sp1/HDAC4/Notch1 Activation

Zhou, Z., Wang, Y., Xing, Y., Pan, S., Wang, W., Yang, J., Wu, W., Zhou, J., Huang, L., Liang, Q., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17111416 · Cited by 2 · see citing works

Disentangling horizontal and vertical Pleiotropy in genetic correlation estimation: introducing the HVP model

Dube, L., Mills, N. T., Le, T. D., Hyppönen, E., & Lee, S. (2025) · Human Genetics · doi:10.1007/s00439-025-02762-w · Cited by 2 · see citing works

Effects of Cherry Consumption on Metabolic Health: A Pilot Clinical Study on Healthy Adults

Carvalho, F., Varges, A., Lahlou, R. A., Bárbara, E. M. P., Santos, I., Fonseca, C., & Silva, L. R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188891 · Cited by 3 · see citing works

Changes in Clinical Manifestations Due to AFLD Retyping Based on the New MAFLD Criteria: An Observational Study Based on the National Inpatient Sample Database

Feng, X., Xuan, R., Dong, Y., Wu, X., Cheng, Y., Yuan, Z., Dong, H., Han, J., Zhong, F., Zhao, J., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13030488 · Cited by 2 · see citing works

Periconceptional Serum Creatinine and Risk of Childhood Autism Spectrum Disorder: A Research Letter

Harel, Z., Jeyakumar, N., Kang, Y., Vélez, M. P., Dayan, N., & Ray, J. G. (2023) · Canadian Journal of Kidney Health and Disease · doi:10.1177/20543581231221892 · Cited by 1 · see citing works

Dietary modifications affect renal recovery during the healing phase following ischemic acute ischemic kidney injury

Jeon, J., Lee, K., Jeon, H., Yang, K. E., Lee, C., Lee, J. E., Kwon, G. Y., Huh, W., & Jang, H. R. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1494660 · Cited by 1 · see citing works

Dexamethasone induces transgenerational inheritance of fetal-derived glomerulosclerosis phenotype in offspring through GR/DNMT3a mediated alterations of the lncRNA-Meg3/Notch signaling pathway

Zhao, X., Wang, Z., Xia, Z., Chen, H., Zhu, Y., Wang, S., Bao, Y., Liu, Y., Wang, H., & Ao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02346-1 · Cited by 1 · see citing works

Risk factors for progression to albuminuria in individuals with newly diagnosed type 2 diabetes: a 5-year cohort study

Zhou, L., Yu, J., Cai, X., Zhu, Y. M., Li, M., Han, X., & Ji, L. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02014-y · Cited by 1 · see citing works

Isolated dyslipidemia triggers early kidney injury through fibrotic remodeling, subcellular lipid accumulation, and AMPK overexpression

Ousmaal, M. E. F., Gaceb, A., Benali, A., & Giaimis, J. (2025) · Ultrastructural Pathology · doi:10.1080/01913123.2025.2575988 · Cited by 1 · see citing works

Noninvasive assessment of metabolic syndrome–related renal injury using magnetic resonance imaging fat fraction and apparent diffusion coefficient: A cross-sectional study

Li, S., Chen, Y.-J., Mei, Y., Mo, X., Chen, J., Li, C., Chen, X., Han, D. H., Li, Y., & Zhang, X. (2025) · Journal of International Medical Research · doi:10.1177/03000605251399039 · Cited by 1 · see citing works

Protective Effects of Chitosan and Rosuvastatin on Renal Structure and Lipid Metabolism in Rabbits Fed a High-Fat Diet

Chagas, C. A. A., Pires, L. A. S., Rodriguez, B. C., Ribeiro, B. F. D. S., Fonseca, A., & Babinski, M. A. (2026) · Medicina · doi:10.3390/medicina62010219 · Cited by 1 · see citing works

The Vicious Cycle of Diabetic Kidney Disease, Vitamin D Deficiency, and Arterial Hypertension

Kurzyna, B., Czebreszuk, P., Szczerbińska, W., Michalak, B., Walędziak, M., & Różańska-Walędziak, A. M. (2026) · Healthcare · doi:10.3390/healthcare14050662 · Cited by 1 · see citing works

The role of gut dysbiosis in endocrine and metabolic derangements of chronic kidney disease: mechanisms, controversies, and future perspectives

Ouyang, Z., Hu, W., Zhu, F., Zhang, Y., Wang, L., & Ye, Q. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1854704 · Cited by 1 · see citing works

The role of gut microbiome disruption in the development of metabolic dysfunction-associated kidney disease

Witkowski, M., Przybyciński, J., Wojciuk, B., Czaja, W., Gołembiewska, N., & Gołembiewska, E. (2026) · Acta Biochimica Polonica · doi:10.3389/abp.2026.16436 · Cited by 1 · see citing works

Exercise as a Molecular Therapeutic Strategy in Metabolic Syndrome: Integrating Cellular Signaling, Organ Crosstalk, and Clinical Translation—A Narrative Review

Fuentes-Barría, H., Aguilera-Eguía, R. A., Alarcón-Rivera, M., & Flores-Fernández, C. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48080850 · Cited by 1 · see citing works

Energy Dynamics in the Metabolic Syndrome: Underpinnings of an Evolving Global Catastrophe

Thorp, K. E., Thorp, E. M., & BS, F. W. (2024) · The Gazette of Medical Sciences · doi:10.46766/thegms.endocrinol.24051901 · Cited by 1 · see citing works

Association of Metabolic Derangement and Postoperative Outcomes in Hernia Repair With Component Separation: A Propensity Score-Matched Nationwide Analysis

Escobar‐Domingo, M. J., Alvarez, A. H., Merle, C., Fanning, J. E., Lee, D., Foppiani, J., Kim, E., Lin, S. J., & Lee, B. T. (2024) · Journal of Surgical Research · doi:10.1016/j.jss.2024.05.046 · Cited by 1 · see citing works

Nonlinear association between blood urea nitrogen to creatinine ratio and obstructive sleep apnea: a cross-sectional study from NHANES

Yang, L., Li, L., Zeng, T., Li, Y., Li, Y., Jiang, D., & Yue, H. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03557-5 · Cited by 1 · see citing works

Impact of Subclinical Atrial Function on the Prognosis of Patients With Atrial Fibrillation and Metabolic Syndrome

Kim, H. (2023) · CardioMetabolic Syndrome Journal · doi:10.51789/cmsj.2024.4.e3 · Cited by 1 · see citing works

Metabolic Syndrome and Kidney Diseases

Boima, V., Agyekum, A. B., & Eduafo, A. K. (2023) · Springer eBooks · doi:10.1007/978-3-031-40116-9_57 · Cited by 1 · see citing works

Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM

Miller, M., Bhatt, D. L., Brinton, E. A., Jacobson, T. A., Steg, P. G., Ketchum, S. B., Pineda, A. L., Tardif, J.-C., & Ballantyne, C. M. (2026) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2025.101387

Association between Renal Function and Individual and Combined Components of Metabolic Syndrome in Elderly People in Brazil

dos Santos, G. M., Nunes, I. F. D. O. C., de Oliveira, F. E., Nogueira, T. R., Sousa, P. V. D. L., Primo, M. G. S., da Paz, S. M. R. S., & de Carvalho, C. M. R. G. (2022) · Current Nutrition & Food Science · doi:10.2174/1573401319666221216101853

Функція нирок у чоловіків із метаболічним синдромом

Luchytskyi, V. Y., Luchytskyi, Y. V., Zubkova, G., Rybalchenko, V. M., & Skladanna, I. I. (2022) · Endokrynologia · doi:10.31793/1680-1466.2022.27-3.251

Kidney Biopsy in a Patient with Cardiorenal Metabolic Syndrome—How to Interpret Histopathology

Zakharova, E., & Vorobyeva, O. A. (2023) · Kidney and Dialysis · doi:10.3390/kidneydial3020015

Is Subcutaneous Rifamycin Application Superior to Saline Application in Hip Hemiarthroplasty?

Çelik, M., Ziroğlu, N., & Bayrak, A. (2023) · Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy · doi:10.4274/bmj.galenos.2023.2022.4-19

Relationship between serum vitamin d levels and the risk of developing metabolic syndrome

López-Chango, V. A., & Pérez, E. A. G. (2023) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt2023433

Research Progress of FGF-21 and CVAI in Type 2 Diabetic Kidney Disease

才巴, 央. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.1371690

Metabolic Syndrome and Kidney Diseases

Boima, V., Agyekum, A. B., & Eduafo, A. K. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_57-1

Potential Reno-protective Influence of Canagliflozin in Male Albino Rats with Metabolic Syndrome

Shamardl, H. A., Sadek, S. A., & Ahmed, A. (2023) · Fayoum University Medical Journal/Fayoum University Medical Journal · doi:10.21608/fumj.2023.323609

Study of The Relation Between Thyroid Function and Metabolic Syndrome in Elderly Patients

Elshourbagy, E., Hassaan, M., Mohamed, S., & Allam, A. A. (2024) · Zagazig University Medical Journal · doi:10.21608/zumj.2024.272004.3187

Metabolic syndrome and chronic kidney disease: Current status and future directions

Prasad, G. V. R. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.210 · Cited by 164 · see citing works

The metabolic syndrome and chronic kidney disease

Zhang, X., & Lerman, L. O. (2016) · Translational research · doi:10.1016/j.trsl.2016.12.004 · Cited by 177 · see citing works

Metabolic Syndrome and Kidney Diseases

Boima, V., Agyekum, A. B., & Eduafo, A. K. (2023) · Springer eBooks · doi:10.1007/978-3-319-12125-3_57-1

Metabolic Syndrome as a Risk Factor for Chronic Kidney Disease

Solis, A. L. G., & Méndez‐Domínguez, N. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815305692125010007

Metabolic syndrome and renal disease

Gluba-Brzózka, A., Mikhailidis, D. P., Lip, G. Y. H., Hannam, S., Rysz, J., & Banach, M. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.013 · Cited by 111 · see citing works